News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sundaram Senthil Vel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Sundaram Senthil Vel (CEO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 2,111 shares
@ $1.41, valued at
$3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Sundaram Senthil Vel (CEO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 280,000 options to buy
@ $5.36, valued at
$1.5M
|
|
| 09/30/2021 |
4
| Sundaram Senthil Vel (CEO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 315,000 options to buy
@ $10.72, valued at
$3.4M
|
|
| 04/19/2021 |
4
| Sundaram Senthil Vel (Director) has filed a Form 4 on Sio Gene Therapies Inc.|
Txns:
| Granted 42,000 options to buy
@ $2.47, valued at
$103.7k
|
|
| 04/17/2020 |
4
| Sundaram Senthil Vel (Director) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 17,500 options to buy
@ $3.45, valued at
$60.4k
|
|
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Sundaram Senthil Vel (CFO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Disposed/sold 126,886 shares
@ $25.5, valued at
$3.2M
Disposed/sold 60,000 options to buy
@ $14.24, valued at
$854.4k
Disposed/sold 108,700 options to buy
@ $14.74, valued at
$1.6M
|
|
| 04/03/2019 |
4
| Sundaram Senthil Vel (CFO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Sold 391 shares
@ $25.31, valued at
$9.9k
|
|
| 01/24/2019 |
4
| Sundaram Senthil Vel (CFO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Granted 108,700 options to buy
@ $14.74, valued at
$1.6M
|
|
| 01/09/2019 |
4
| Sundaram Senthil Vel (CFO) has filed a Form 4 on Nightstar Therapeutics plc|
Txns:
| Sold 406 shares
@ $12.9808, valued at
$5.3k
|
|
|
|